Leukocyte glucose index as a novel biomarker for COVID-19 severity

Leukocyte glucose index as a novel biomarker for COVID-19 severity

Abstract The severity of coronavirus disease 2019 (COVID-19) quickly progresses with unfavorable outcomes due to the host immune response and metabolism alteration. Hence, we hypothesized that leukocyte glucose index (LGI) is a biomarker for severe COVID-19. This study involved 109 patients and the...

Full description

Bibliographic Details
Main Authors: Wendy Marilú Ramos-Hernández, Luis F. Soto, Marcos Del Rosario-Trinidad, Carlos Noe Farfan-Morales, Luis Adrián De Jesús-González, Gustavo Martínez-Mier, Juan Fidel Osuna-Ramos, Fernando Bastida-González, Víctor Bernal-Dolores, Rosa María del Ángel, José Manuel Reyes-Ruiz
Format: Article
Language:English
Published: Nature Portfolio 2022-09-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-022-18786-5

Internet

https://doi.org/10.1038/s41598-022-18786-5

Similar Items